The challenge of developmental therapeutics for adrenocortical carcinoma


Adrenocortical carcinoma (ACC) is a rare disease with an estimated incidence of only 0.7 new cases per million per year. Approximately 30-70% of the patients present with advanced disease with very poor prognosis and without effective therapeutic options. In the recent years, unprecedented progresses in cancer biology and genomics have fostered the… (More)
DOI: 10.18632/oncotarget.8774


3 Figures and Tables

Slides referencing similar topics